#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3736777	Functional	Antiparasitic activity against Toxoplasma gondii RH tachyzoite expressing beta-galactosidase assessed as inhibition of tachyzoite invasion into human foreskin fibroblast host cells after 96 hrs by colorimetric microtitre assay	Toxoplasma gondii	22	ALA3734718	organism-based format	Scientific Literature
2.	ALA3773071	Functional	Antiprotozoan activity against Toxoplasma gondii infected in fibroblasts assessed as growth inhibition after 44 hrs by beta-galactosidase reporter assay	Toxoplasma gondii	22	ALA3769379	organism-based format	Scientific Literature
3.	ALA3773079	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as reduction of parasite burden in peritoneal fluid at 50 mg/kg, po qd administered for 5 days measured 24 hrs post last dose by hemocytometer-based fluorescence microscopy	Toxoplasma gondii	1	ALA3769379	organism-based format	Scientific Literature
4.	ALA3773080	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as reduction of parasite burden in peritoneal fluid at 20 mg/kg, po qd administered for 5 days measured 24 hrs post last dose by hemocytometer-based fluorescence microscopy	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
5.	ALA3773081	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as reduction of parasite burden in peritoneal fluid at 5 to 10 mg/kg, po bid administered for 5 days measured 24 hrs post last dose by hemocytometer-based fluorescence microscopy	Toxoplasma gondii	1	ALA3769379	organism-based format	Scientific Literature
6.	ALA3773082	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as parasite level in spleen at 20 mg/kg, po qd administered for 5 days measured 24 hrs post last dose by quantitative RT-PCR analysis	Toxoplasma gondii	1	ALA3769379	organism-based format	Scientific Literature
7.	ALA3773083	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as parasite level in spleen at 20 to 50 mg/kg, po qd administered for 5 days measured 24 hrs post last dose by quantitative RT-PCR analysis relative to control	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
8.	ALA3773426	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as reduction of parasite burden in brain at 20 to 50 mg/kg, po qd administered for 5 days measured 24 hrs post last dose by quantitative RT-PCR analysis relative to control	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
9.	ALA3773433	Functional	Antiprotozoan activity against Toxoplasma gondii infected in fibroblasts assessed as growth inhibition at low concentration after 2 days by beta-galactosidase reporter assay	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
10.	ALA3773434	Functional	Antiprotozoan activity against Toxoplasma gondii overexpressing wild type CDPK1 infected in fibroblasts assessed as growth inhibition at low concentration after 2 days by beta-galactosidase reporter assay	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
11.	ALA3773435	Functional	Antiprotozoan activity against Toxoplasma gondii overexpressing CDPK1 G128M mutant infected in fibroblasts assessed as growth inhibition at low concentration after 2 days by beta-galactosidase reporter assay	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
12.	ALA3773436	Functional	Antiprotozoan activity against Toxoplasma gondii RH infected in CF-1 mouse assessed as reduction of parasite burden in peritoneal fluid at 20 to 40 mg/kg, po bid administered for 5 days measured 24 hrs post last dose by hemocytometer-based fluorescence microscopy relative to control	Toxoplasma gondii	1	ALA3769379	organism-based format	Scientific Literature
13.	ALA3773439	Functional	Antiprotozoan activity against Toxoplasma gondii overexpressing CDPK1 G128M mutant infected in fibroblasts assessed as growth inhibition at high concentration after 2 days by beta-galactosidase reporter assay	Toxoplasma gondii	2	ALA3769379	organism-based format	Scientific Literature
14.	ALA3832817	Functional	AntiToxoplasma gondii activity data Inhibition of plaque forming efficiency (%) Experiment A	Toxoplasma gondii	15	ALA3832761	organism-based format	MMV Pathogen Box
15.	ALA3832818	Functional	AntiToxoplasma gondii activity data Inhibition of plaque forming efficiency (%) Experiment B	Toxoplasma gondii	6	ALA3832761	organism-based format	MMV Pathogen Box
16.	ALA3832819	Functional	AntiToxoplasma gondii activity data 2-day killing assay: inhibition at 10 uM (%) Experiment C	Toxoplasma gondii	15	ALA3832761	organism-based format	MMV Pathogen Box
17.	ALA3832820	Functional	AntiToxoplasma gondii activity data 2-day killing assay: inhibition at 10 uM (%) Experiment D	Toxoplasma gondii	15	ALA3832761	organism-based format	MMV Pathogen Box
18.	ALA3832821	Functional	AntiToxoplasma gondii activity data 2-day killing assay: inhibition at 10 uM (%) Experiment E	Toxoplasma gondii	15	ALA3832761	organism-based format	MMV Pathogen Box
19.	ALA3832822	Functional	AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F	Toxoplasma gondii	14	ALA3832761	organism-based format	MMV Pathogen Box
20.	ALA3832823	Functional	AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G	Toxoplasma gondii	9	ALA3832761	organism-based format	MMV Pathogen Box